Skip to main content
. 2018 Feb 1;2018(2):CD001269. doi: 10.1002/14651858.CD001269.pub6

aa Monto 2009.

Methods Third epidemic season (2007 to 2008) of aa Ohmit 2006 and aa Ohmit 2008
Participants A total of 1952 healthy adults between the ages of 18 and 49 years were enrolled. Some had been also enrolled in the 2 previous seasons.
Interventions Newly enrolled participants were recruited from the community around 4 university campuses in Michigan. Allocation methods are the same as for aa Ohmit 2006 and aa Ohmit 2008.
For the 2007 to 2008 season vaccine composition was the following:
  • Fluzone (Sanofi Pasteur, inactivated trivalent vaccine intramuscular): 15 μg of haemagglutinin from each of the following strains in a 0.5 mL dose: A/Solomon Islands/3/2006 (H1N1), A/Wisconsin/67/2005 (H3N2), and B/Malaysia/2506/2004 (B/Victoria lineage).

  • FluMist (MedImmune, live attenuated vaccine, intranasal): 106.5‐7.5 fluorescent focus units of live attenuated influenza virus reassortants of the same strains as used for the inactivated formulation in a 0.2 mL dose.

Outcomes Same outcomes as aa Ohmit 2008
Notes Funding source ‐ mixed
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection bias) 
 All outcomes Unclear risk Unclear
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unclear
Summary assessment Unclear risk Unclear